Cancer Archives

kuros cytos biotechnologies biosciences vaccine hepatitis merger bone biosurgeries

News and Trends 20 Jan 2016

Swiss Biotech Merger: Bones + Oncology + Vaccines?

Kuros Biosurgery in Zürich (Switzerland), the bone remodelling biotech for trauma patients, today officially acquired Cytos Biotechnology in Schlieren, the two of which are now to be rebranded ‘Kuros Biosciences’ in a Swiss Stock Exchange merger. Kuros is developing innovative products for tissue repair and regeneration. The company is a spin-off of the Swiss Federal […]

January 20, 2016 - 2 minutesmins - By Dani Bancroft

cancer biotech killers deadliest oncology therapies immunooncology

News and Trends 19 Jan 2016

Top 8 Deadliest Cancers and their Potential Cures

With more than 200 types of cancer, the possibility of developing a Universal Cure is in reality, a myth. However, the fight against the World’s Deadliest Cancers is far from being lost…and there lies hope in the Biotech Industry. Simply by having a quick look through our articles, we can easily confirm that cancer is […]

January 19, 2016 - 7 minutesmins - By Dani Bancroft

News and Trends 15 Jan 2016

Biotech of the week: Kiadis Pharma, Immuno-therapy made in Amsterdam

This week we say ‘auf Wiedersehen’ to Germany and head West to the Netherlands and it’s capital city, Amsterdam. This city really does have it all, whether you’re looking for history, architecture or something more indulgent… it is also the location of our biotech of the week: Kiadis Pharma City: Amsterdam, Netherlands Founded: 1997 Employees: 23 (as of 12/2015) […]

January 15, 2016 - 2 minutesmins - By Philip Hemme

f star fcab immunoncology abbvie babraham cancer

News and Trends 13 Jan 2016

UK Biotech starts 2016 by signing a (Massive?) Immuno-Oncology Deal with AbbVie

This year has started with a rush of deals for many Biotechs. F-Star another such company, now signing up for an Immuno-Oncology deal with AbbVie using Bispecific Antibodies. Financial terms were not disclosed but in regards to the hype of the Immuno-Oncology field, it could be pretty high. F-Star is a Cambridge company based at the Babraham […]

January 13, 2016 - 2 minutesmins - By Philip Hemme

cellectis ucart19 nature cancer car t cell leukemia crs cytokine

News and Trends 12 Jan 2016

Cellectis has Discovered an ‘On-Switch’ to Make CAR-T Safer and Better Controlled

Cellectis researchers have managed to come up with a new CAR architecture with a small-molecule triggered ‘on-switch’, permitting better control and safety in CAR T-cell therapy, as published in Nature. As we discussed during our interview with Andre Choulika, CEO of Cellectis, last month, one major drawback to CAR-T treatment for cancer is the lack of […]

January 12, 2016 - 3 minutesmins - By Dani Bancroft

prostate cancer trod encage leuven ucl vesalius

News and Trends 11 Jan 2016

TROD’s MedTech for Prostate Cancer Kills Tumor Cells with Radio Waves

TROD Medical, the medical device company developing tools for focal ablation, today announced that it has received CE Mark Approval for its Encage device. Encage is a breakthrough in treatment for prostate cancer, one of the most common soft tissue cancers in the world with around 240,000 new cases every year in the US alone. […]

January 11, 2016 - 2 minutesmins - By Dani Bancroft

innate pharma immunooncology biotech cancer orega sanofi

News and Trends 11 Jan 2016

A French Biotech is Monopolising Immuno-Oncology with Big Euro Deals

Marseille’s Innate Pharma is building an Immuno-Oncology Monopoly, deal by deal. Selling to the French Pharma Giant, Sanofi, this 112 employee biotech has used their Sanofi-income to buy up Lyon-based Orega Biotech‘s checkpoint inhibitor program. Sanofi and Innate Pharma will work together on the generation and evaluation of up to two bispecific NK cell engagers, […]

January 11, 2016 - 3 minutesmins - By Dani Bancroft

Universal cancer diagnostic test illumina bill gates grail guardant health ngs

News and Trends 11 Jan 2016

How about the $100M Holy ‘GRAIL’ in Cancer Diagnostics? A Universal Test Start-up Faces German Competition

Illumina, the €22Bn Market cap NGS specialist, and Bill Gates pooled a $100M to fund the startup, ‘Grail’, which will be used to find a universal cancer detection test for Doctors. The startup will be based in San Francisco (US) with additional financial backing to include Bill Gates amongst others. The tests in question are […]

January 11, 2016 - 3 minutesmins - By Dani Bancroft

transgene pecvex oncolytic liver cancer lee pharma

News and Trends 11 Jan 2016

Transgene shares jump 50% in 2 days After Announcing Phase III Trial for Liver Cancer

This multinational Phase III Trial for an Oncolytic Immunotherapy for Advanced Liver Cancer could be what really defines French Transgene as the underdog which finally sprang to fame. Transgene, in Strasbourg, was founded in 1979, as France’s oldest Biotech (only 3 years after Genentech was born on the other side of the Atlantic). However, unlike Genentech, […]

January 11, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 8 Jan 2016

Biotech of the week: Glycotope, the Biggest Biotech in Berlin

After the Christmas and New Year, we continue our journey across Europe to have a glimpse of it’s vast number of Biotechs. This week, we leave Finland behind and head South-West across the Baltic Sea and back to our home town, Berlin, to visit our biotech of the week, Glycotope. City: Berlin, Germany Founded: 2001 Employees: 200 (as of […]

January 8, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 7 Jan 2016

3 French Bioentrepreneurs are Awarded for Being Stubborn

Building a company is extremely difficult and obstination is sometimes needed to reach success. The organisation, France Biotech, has given a price to the founder of Innate-Pharma, OSE Pharma and Effimune for their respective success. Why? From left to right, Hervé Brailly, CEO & Founder of Innate-Pharma, Denis Lucquin, Managing Director of Sofinnova Partners, Maryvonne Hiance, […]

January 7, 2016 - 3 minutesmins - By Philip Hemme

merck msd cancer immunoncology complix alphabody

News and Trends 7 Jan 2016

Alphabody Platform for Cancer Draws in €260M Discovery Deal with MSD

Complix is a Belgian Immuno-Oncology Biotech with a proprietary Alphabody platform, which has now attracted a €260M strategic drug discovery collaboration with Merck Sharp & Dohme (MSD). Under the terms of the agreement, Complix will use its proprietary Alphabody platform to tackle two intra-cellular cancer targets. One example is the myeloid leukemia cell-1 protein (MCL-1), […]

January 7, 2016 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

Swiss Biotech Merger: Bones + Oncology + Vaccines?

Top 8 Deadliest Cancers and their Potential Cures

Biotech of the week: Kiadis Pharma, Immuno-therapy made in Amsterdam

UK Biotech starts 2016 by signing a (Massive?) Immuno-Oncology Deal with AbbVie

Cellectis has Discovered an ‘On-Switch’ to Make CAR-T Safer and Better Controlled

TROD’s MedTech for Prostate Cancer Kills Tumor Cells with Radio Waves

A French Biotech is Monopolising Immuno-Oncology with Big Euro Deals

How about the $100M Holy ‘GRAIL’ in Cancer Diagnostics? A Universal Test Start-up Faces German Competition

Transgene shares jump 50% in 2 days After Announcing Phase III Trial for Liver Cancer

Biotech of the week: Glycotope, the Biggest Biotech in Berlin

3 French Bioentrepreneurs are Awarded for Being Stubborn

Alphabody Platform for Cancer Draws in €260M Discovery Deal with MSD

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!